
Dr Robert Gabbay on COVID-19 Vaccinations in the Diabetes Community
Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, discusses COVID-19 vaccinations among people with diabetes as they have been disproportionally affected by the pandemic.
Efforts to address COVID-19 in the diabetes community are based, in part, on early recognition that these individuals would be disproportionately impacted, said Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association.
Transcript
Is the focus on how much COVID-19 has harmed those with diabetes making an impact? Are people with diabetes getting vaccinated at rates that will make a difference?
There's been a big effort to address COVID-19 in the
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.